Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2

Laszlo Gyenis , Agnieszka Kuś , Maria Bretner , David W. Litchfield

Abstract

CK2 is a constitutively active protein kinase with key regulatory roles in many cellular signaling events which has been implicated in several human diseases. To investigate its roles in biological events and potential as a therapeutic target, several potent CK2 inhibitors have been developed including TBB and its derivatives that have been employed in many studies. Despite the utility of these compounds, a precise understanding of their mode of action within cells remains incomplete. In fact, cells are typically treated with inhibitor concentrations (> 5 μM) that are orders of magnitude higher than their in vitro inhibitory constants (< 0.05 μM). Accordingly, we hypothesized that CK2 inhibitors could have off-target effects that are not recognized when inhibitors are profiled using panels of recombinant protein kinases. To address this issue, we combined structural modeling with inhibitor-affinity purification and proteomics to test the specificity of derivatives of TBB using whole cell lysates of HeLa cells. While these studies confirmed that CK2 does bind to the immobilized inhibitor, several other abundant ATP/GTP-binding proteins were also identified and confirmed. These results suggest that highly abundant nucleotide binding proteins may limit the bioavailability of the free inhibitor and interactions with CK2 in the cellular environment. This article is part of a Special Issue entitled: From protein structures to clinical applications.
Author Laszlo Gyenis - [Western University]
Laszlo Gyenis,,
-
-
, Agnieszka Kuś (FC / IBC / DDTB)
Agnieszka Kuś,,
- Department Of Drug Technology And Biotechnology
, Maria Bretner (FC / IBC / DDTB)
Maria Bretner,,
- Department Of Drug Technology And Biotechnology
, David W. Litchfield - [Western University]
David W. Litchfield,,
-
-
Journal seriesJournal of Proteomics, ISSN 1874-3919
Issue year2013
Vol81
Pages70-79
Publication size in sheets0.5
Keywords in EnglishCK2, protein kinase inhibitors, TBB, chemoproteomics, inhibitor profiling, mass spectrometry
ASJC Classification1303 Biochemistry; 1304 Biophysics
DOIDOI:10.1016/j.jprot.2012.09.017
URL http://www.sciencedirect.com/science/article/pii/S1874391912006616
Languageen angielski
File
journalofproteomics_2013_81_70.pdf 690.1 KB
Score (nominal)35
Score sourcejournalList
ScoreMinisterial score = 35.0, 01-02-2020, ArticleFromJournal
Ministerial score (2013-2016) = 35.0, 01-02-2020, ArticleFromJournal
Publication indicators Scopus Citations = 13; WoS Citations = 11; Scopus SNIP (Source Normalised Impact per Paper): 2013 = 1.011; WoS Impact Factor: 2013 = 3.929 (2) - 2013=4.12 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back
Confirmation
Are you sure?